Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
146481
-
146482
-
146483
-
146484
-
146485
-
146486
-
146487
-
146488
-
146489
-
146490
-
146491
-
146492
-
146493
-
146494
-
146495
-
146496
-
146497
-
146498
Expression of microRNA-548ac <i>in vitro</i> and effect of SNP rs1414273.
Published 2019“…(<b>C</b>) Relative expression of hsa-mir-548ac precursor transcripts after transient transfection. A more than 10-fold decrease in the precursor levels was consistently observed from the 24 h to the 48 h time point. …”
-
146499
Rhesus macaque CD4 alleles are universally defective for HIV-1 entry.
Published 2019“…Genotype information was used to phase SNPs using Phase 2.1 [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000304#pbio.3000304.ref081" target="_blank">81</a>,<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000304#pbio.3000304.ref082" target="_blank">82</a>] in DNAsp v5 [<a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.3000304#pbio.3000304.ref083" target="_blank">83</a>]. …”
-
146500
DataSheet_1_Dynamic gut microbiota changes in patients with advanced malignancies experiencing secondary resistance to immune checkpoint inhibitors and immune-related adverse event...
Published 2023“…While the abundance of IgA-coated bacteria was stable in the SR cohort, there was a temporary decrease upon ICI treatment initiation and reestablishment after continuation of ICI treatment in the NSR cohort (primary ICI response: 0.06, IQR 0.04-0.10; durable ICI response: 0.11, IQR 0.07-0.14; P=0.042). …”